FDA-Inspected Site

Theragen, Inc

4 FDA inspections are on record for Theragen, Inc in Jacksonville, United States.

Clean· No action indicated

Jacksonville, United States · Last updated July 10, 2026

Overview

  • 4 FDA inspections are on record.
  • 3 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-01-25.

At a glance

Inspections

4

Form 483s

3

EIRs

0

Last outcome

Clean

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
24 Jan 2024 – 25 Jan 2024Medical Devices & Rad HealthClean
7 Sep 2021 – 10 Sep 2021Medical Devices & Rad Health483View 483 →
18 Feb 2020 – 20 Feb 2020Medical Devices & Rad Health483View 483 →
20 May 2019 – 23 May 2019Medical Devices & Rad Health483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

10 Sep 2021
21 CFR 820.40(a)

Not approved or obsolete document retrieval

Cited by Jude C Dike

20 Feb 2020
21 CFR 820.100(b)

Documentation

Cited by Wilfred A Darang

20 Feb 2020
21 CFR 820.100(b)

Documentation

Cited by Wilfred A Darang

20 Feb 2020
21 CFR 820.100(b)

Documentation

Cited by Wilfred A Darang

23 May 2019
21 CFR 803.17(a)(1)

Lack of System for Event Evaluations

Cited by Tiki Dixon

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 820.100(b)Cited across public-safe Form 483 observations3x
21 CFR 803.17(a)(1)Cited across public-safe Form 483 observations2x
21 CFR 820.30(i)Cited across public-safe Form 483 observations2x
21 CFR 820.90(a)Cited across public-safe Form 483 observations2x
21 CFR 820.40(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Theragen, Inc's 3 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat